Galectin-3 is a Nanotherapeutic Target in Graft-versus-Host Disease Mediated Kidney InjuryMagdalini Panagiotakopoulou, Daniel A. Heller, Anastasia I. Kousa et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0